Your browser doesn't support javascript.
loading
An official European Respiratory Society statement: pulmonary haemodynamics during exercise.
Kovacs, Gabor; Herve, Philippe; Barbera, Joan Albert; Chaouat, Ari; Chemla, Denis; Condliffe, Robin; Garcia, Gilles; Grünig, Ekkehard; Howard, Luke; Humbert, Marc; Lau, Edmund; Laveneziana, Pierantonio; Lewis, Gregory D; Naeije, Robert; Peacock, Andrew; Rosenkranz, Stephan; Saggar, Rajeev; Ulrich, Silvia; Vizza, Dario; Vonk Noordegraaf, Anton; Olschewski, Horst.
Affiliation
  • Kovacs G; Medical University of Graz, Dept of Internal Medicine, Division of Pulmonology, Graz, Austria gabor.kovacs@klinikum-graz.at.
  • Herve P; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
  • Barbera JA; Centre Chirugical Marie Lannelongue, Thoracic and Vascular Surgery, Le Plessis-Robinson, France.
  • Chaouat A; Dept of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Chemla D; Biomedical Research Networking Center on Respiratory Diseases, Madrid, Spain.
  • Condliffe R; CHRU Nancy, Département de Pneumologie, Vandoeuvre-lès-Nancy, France.
  • Garcia G; Université de Lorraine, INGRES, EA 7298, Vandoeuvre-lès-Nancy, France.
  • Grünig E; Centre de Référence de l'Hypertension Pulmonaire, Université Paris-Sud - Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, France.
  • Howard L; Royal Hallamshire Hospital, Sheffield Pulmonary Vascular Disease Unit, Sheffield, UK.
  • Humbert M; Centre de Référence de l'Hypertension Pulmonaire, Université Paris-Sud - Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, France.
  • Lau E; Thoraxclinic Heidelberg, Centre for Pulmonary Hypertension, Heidelberg, Germany.
  • Laveneziana P; Imperial College NHS Healthcare NHS Trust, National Pulmonary Hypertension Service, London, UK.
  • Lewis GD; Centre de Référence de l'Hypertension Pulmonaire, Université Paris-Sud - Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, France.
  • Naeije R; Royal Prince Alfred Hospital, Respiratory Medicine, Camperdown, Australia.
  • Peacock A; Sorbonne Universités, UPMC Université Paris 06, INSERM, UMRS_1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.
  • Rosenkranz S; Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée (Département 'R3S', Pôle PRAGUES), Paris, France.
  • Saggar R; Cardiology Division and Pulmonary Unit, Massachusetts General Hospital, Boston, MA, USA.
  • Ulrich S; Faculty of Medicine, Free University of Brussels, Physiology, Brussels, Belgium.
  • Vizza D; Scottish Pulmonary Vascular Unit, Glasgow, UK.
  • Vonk Noordegraaf A; University of Cologne, Klinik III fuer Innere Medizin, Cologne, Germany.
  • Olschewski H; Banner University Medical Center, University of Arizona, Phoenix, AZ, USA.
Eur Respir J ; 50(5)2017 11.
Article in En | MEDLINE | ID: mdl-29167297
ABSTRACT
There is growing recognition of the clinical importance of pulmonary haemodynamics during exercise, but several questions remain to be elucidated. The goal of this statement is to assess the scientific evidence in this field in order to provide a basis for future recommendations.Right heart catheterisation is the gold standard method to assess pulmonary haemodynamics at rest and during exercise. Exercise echocardiography and cardiopulmonary exercise testing represent non-invasive tools with evolving clinical applications. The term "exercise pulmonary hypertension" may be the most adequate to describe an abnormal pulmonary haemodynamic response characterised by an excessive pulmonary arterial pressure (PAP) increase in relation to flow during exercise. Exercise pulmonary hypertension may be defined as the presence of resting mean PAP <25 mmHg and mean PAP >30 mmHg during exercise with total pulmonary resistance >3 Wood units. Exercise pulmonary hypertension represents the haemodynamic appearance of early pulmonary vascular disease, left heart disease, lung disease or a combination of these conditions. Exercise pulmonary hypertension is associated with the presence of a modest elevation of resting mean PAP and requires clinical follow-up, particularly if risk factors for pulmonary hypertension are present. There is a lack of robust clinical evidence on targeted medical therapy for exercise pulmonary hypertension.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Resistance / Cardiac Output / Ventricular Dysfunction, Left / Exercise Test / Hypertension, Pulmonary Type of study: Guideline / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur Respir J Year: 2017 Document type: Article Affiliation country: Austria

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Resistance / Cardiac Output / Ventricular Dysfunction, Left / Exercise Test / Hypertension, Pulmonary Type of study: Guideline / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur Respir J Year: 2017 Document type: Article Affiliation country: Austria